FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Start Over | Back to Previous Screen

Sodium Chloride Injection USP, 0.9% Vials and Syringes
Status: Currently in Shortage
»Date first posted: 06/21/2018
»Therapeutic Categories: Other

Expand all

Fresenius Kabi USA, LLC (Revised 11/28/2018)

Company Contact Information:
888-386-1300

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
Sodium Chloride Injection USP, Single dose plastic vial, 0.9%, (18 mg per 2 mL)(9 mg per mL) (NDC 63323-186-02) Backordered. Next release date not available at this time. All Sodium Chloride 0.9% vial presentations are on intermittent back order and will be released as the product becomes available. Product will ship into the wholesalers. Increase in Demand
Sodium Chloride Injection USP, Single dose plastic vial, 0.9%, (90 mg per 10 mL)(9 mg per mL) (NDC 63323-186-10) Backordered. Next release Q1 - 2019 Manufacturing delay
Sodium Chloride Injection USP, Single dose plastic vial, 0.9%, (180 mg per 20 mL)(9 mg per mL) (NDC 63323-186-20) Backordered. Next release Q1 - 2019 Manufacturing delay
Sodium Chloride Injection USP, Single dose tear top vial, 0.9%, (900 mg per 100 mL)(9 mg per mL) (NDC 63323-186-00) Backordered. Next release date not available at this time. Increase in Demand

Hospira, Inc. (Revised 12/06/2018)

Company Contact Information:
844-646-4398

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
10 mL (0.9%); Single Dose Plastic Fliptop Vial (NDC 00409-4888-10) Available Other
10 mL (0.9%); Single Dose LifeShield Plastic Fliptop Vial (NDC 00409-4888-12) Available Other
0.9%; Single Dose Plastic Fliptop Vial (NDC 00409-4888-20) Limited Supply Available. Next Delivery and Estimated Recovery: March 2019 Shoratage per Manufacturer: Manuafacturing Delay Other
0.9%; Single Dose Plastic Fliptop Vial (NDC 00409-4888-50) Next Delivery: January 2019; Estimated Recovery: June 2019 Demand increase for the drug

Medefil, Inc. (New 08/02/2018)

Company Contact Information:
630-682-4600

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
Sodium Chloride Injection, USP, 0.9%, in a plastic syringe (10 mL) (NDC 64253-202-30) Available Check wholesalers for inventory Available

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English